Showing results (3171-3180 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|June 8, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Cancer Immunology, Immunotherapy : CII|May 29, 2023
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 studyMatteo Santoni, Zin W Myint, Thomas Büttner, et al.
Cancer Immunology, Immunotherapy : CII|September 21, 2023
Metabolic diversity of tumor-infiltrating T cells as target for anti-immune therapeuticsPeipei Li, Fangchao Li, Yanfei Zhang, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2023
Tumor immunology meets oncology (TIMO) XVI, July 07-09 2022 in Halle/Saale, GermanyBarbara Seliger
Cancer Immunology, Immunotherapy : CII|February 25, 2026
Tumor-specific antibody cocktail treatment suppresses colorectal tumor growth in miceGirja S Shukla, Stephanie C Pero, Yujing Sun, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2026
Human CD3 complex is required for the generation of T-cell receptor-like chimeric antigen receptor targeting WT1 in natural killer cellsSudjit Luanpitpong, Jirarat Poohadsuan, Parinya Samart, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2026
Mitochondrial impairment and mTORC1 signalling exhaustion define NK Cell dysfunction progression in melanomaEimear Mylod, Jack Behan, Dina Baier, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2026
Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patternsD Quatannens, Y Verhoeven, S van der Heijden, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2026
Metformin drives HIF-1α-mediated dual metabolic reprogramming to enhance γδ T cell therapy in triple-negative breast cancerXuping Qin, Haowen Zhong, Meize Liu, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2026
Heterogeneity and prognostic significance of mast cell subsets in the tumor microenvironment of prostate cancerRuizhe Fang, Shuyang Zhao, Minggui Si, et al.
Pageof 652